3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro(1,8)naphthyridin-2-yl)propyl)imidazolidin-1-yl)propionic acid,
3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-(1,8)naphthyridin-2-yl)propyl)imidazolidin-1-yl)propionic acid,
L-000845704,
MK-0429,
MOTNI-propionic acid,
MK-0429,
UNII-1JL033A2D0,
CHEMBL145085,
227963-15-7,
1JL033A2D0,
MK-429,
Alpha-V Beta-3 Antagonist,
GTPL9689,
SCHEMBL2064856,
BDBM50134778,
MK0429,
compound 6 [PMID:14561098],
HY-15102,
CS-0003761,
J1.969.455K,
Q27252505,
(3S)-3-(6-Methoxy-3-pyridyl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid,
(3S)-3-(6-methoxypyridin-3-yl)-3-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]imidazolidin-1-yl]propanoic acid,
(betaS)-beta-(2-Methoxy-5-pyridyl)-3-[3-(1,2,3,4-tetrahydro-1,8-naphthyridine-7-yl)propyl]-2-oxoimidazolidine-1-propanoic acid,
(S)-3-(6-Methoxy-pyridin-3-yl)-3-{2-oxo-3-[3-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-propyl]-imidazolidin-1-yl}-propionic acid,
(S)-3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid,
3-Pyridinepropanoic acid, 6-methoxy-beta-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)-1-imidazolidinyl)-, (betaS)-,
MOTNI-propionic acid,
HGFOOLONGOBCMP-IBGZPJMESA-N,
CID9853559,
CID 9824473,
L-000845704,
C478626,
3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro(1,8)naphthyridin-2-yl)propyl)imidazolidin-1-yl)propionic acid,
3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-(1,8)naphthyridin-2-yl)propyl)imidazolidin-1-yl)propionic acid,